Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition

The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and the tumour-initiating capability of head-and-neck squamous cell carcinoma cells. The epithelial–mesenchymal transition (EMT), one of the main...

Full description

Saved in:
Bibliographic Details
Published inNature cell biology Vol. 12; no. 10; pp. 982 - 992
Main Authors Yang, Muh-Hwa, Hsu, Dennis Shin-Shian, Wang, Hsei-Wei, Wang, Hsiao-Jung, Lan, Hsin-Yi, Yang, Wen-Hao, Huang, Chi-Hung, Kao, Shou-Yen, Tzeng, Cheng-Hwai, Tai, Shyh-Kuan, Chang, Shyue-Yih, Lee, Oscar Kuang-Sheng, Wu, Kou-Juey
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2010
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and the tumour-initiating capability of head-and-neck squamous cell carcinoma cells. The epithelial–mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.
AbstractList The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.
The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and the tumour-initiating capability of head-and-neck squamous cell carcinoma cells. The epithelial–mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.
The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.
Audience Academic
Author Lee, Oscar Kuang-Sheng
Wang, Hsiao-Jung
Yang, Wen-Hao
Hsu, Dennis Shin-Shian
Tai, Shyh-Kuan
Tzeng, Cheng-Hwai
Huang, Chi-Hung
Wu, Kou-Juey
Chang, Shyue-Yih
Lan, Hsin-Yi
Wang, Hsei-Wei
Yang, Muh-Hwa
Kao, Shou-Yen
Author_xml – sequence: 1
  givenname: Muh-Hwa
  surname: Yang
  fullname: Yang, Muh-Hwa
  email: mhyang2@vghtpe.gov.tw
  organization: Institute of Clinical Medicine, National Yang-Ming University, Institute of Biotechnology in Medicine, National Yang-Ming University, Division of Hematology-Oncology, Department of Medicine, Taipei Veterans General Hospital, Genomic Research Center, Taipei Veterans General Hospital
– sequence: 2
  givenname: Dennis Shin-Shian
  surname: Hsu
  fullname: Hsu, Dennis Shin-Shian
  organization: Institute of Clinical Medicine, National Yang-Ming University
– sequence: 3
  givenname: Hsei-Wei
  surname: Wang
  fullname: Wang, Hsei-Wei
  organization: Institute of Clinical Medicine, National Yang-Ming University, Genomic Research Center, Taipei Veterans General Hospital, Institute of Microbiology & Immunology
– sequence: 4
  givenname: Hsiao-Jung
  surname: Wang
  fullname: Wang, Hsiao-Jung
  organization: Institute of Clinical Medicine, National Yang-Ming University
– sequence: 5
  givenname: Hsin-Yi
  surname: Lan
  fullname: Lan, Hsin-Yi
  organization: Institute of Clinical Medicine, National Yang-Ming University
– sequence: 6
  givenname: Wen-Hao
  surname: Yang
  fullname: Yang, Wen-Hao
  organization: Institute of Clinical Medicine, National Yang-Ming University
– sequence: 7
  givenname: Chi-Hung
  surname: Huang
  fullname: Huang, Chi-Hung
  organization: Taiwan Advance Biopharm, Inc
– sequence: 8
  givenname: Shou-Yen
  surname: Kao
  fullname: Kao, Shou-Yen
  organization: Department of Dentistry, Taipei Veterans General Hospital
– sequence: 9
  givenname: Cheng-Hwai
  surname: Tzeng
  fullname: Tzeng, Cheng-Hwai
  organization: Division of Hematology-Oncology, Department of Medicine, Taipei Veterans General Hospital
– sequence: 10
  givenname: Shyh-Kuan
  surname: Tai
  fullname: Tai, Shyh-Kuan
  organization: Department of Otolaryngology, Taipei Veterans General Hospital
– sequence: 11
  givenname: Shyue-Yih
  surname: Chang
  fullname: Chang, Shyue-Yih
  organization: Genomic Research Center, Taipei Veterans General Hospital, Department of Otolaryngology, Taipei Veterans General Hospital
– sequence: 12
  givenname: Oscar Kuang-Sheng
  surname: Lee
  fullname: Lee, Oscar Kuang-Sheng
  organization: Institute of Clinical Medicine, National Yang-Ming University, Department of Medical Research & Education, Taipei Veterans General Hospital
– sequence: 13
  givenname: Kou-Juey
  surname: Wu
  fullname: Wu, Kou-Juey
  email: mhyang2@vghtpe.gov.tw
  organization: Genomic Research Center, Taipei Veterans General Hospital, Institute of Biochemistry & Molecular Biology, National Yang-Ming University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20818389$$D View this record in MEDLINE/PubMed
BookMark eNpt0s1u3CAQAGBUpWr-qr5BZSWHtAcnYIyBYxq1aaRIlZL0jDAeb4hsvDVYbW59h7xhn6Rj7abRphEHEHyMhhl2yVYYAhDyjtFjRrk6Ca4uqNavyA4rZZWXldRb87oSueS62Ca7Md5RysqSyjdku6CKKa70Djn_1HuW-ZhBjBCSt13mQ3bz08fEch-ayUGTwdKnW-jw8M_vhx4Qutv7HmkabYg--SHsk9et7SK8Xc975PuXzzdnX_PLb-cXZ6eXuRNUpryQzMrWtRTKBjRvnFA1E7Ksayoc57VqZaOtla6pLNe6KoSyoJgsRdEyhmSPHK3iLsfhxwQxmd5HB11nAwxTNFJIJgVylAfP5N0wjQGTQ1RRLSQvER2u0MJ2YHxoB3ySm0Oa04JrqjRnc6jjFxSOBnrvsBOtx_2NCx83LqBJ8Cst7BSjubi-2rTv13lOdQ-NWY6-t-O9eewRgnwF3DjEOEJrnE92Ljpm4TvDqJn_gFn_gacS_fOPIf-XH1YyoggLGJ9K9Jz-BaR_u6U
CitedBy_id crossref_primary_10_1002_mc_23296
crossref_primary_10_1007_s00018_016_2313_z
crossref_primary_10_3892_ijmm_2017_3320
crossref_primary_10_1177_1010428318784807
crossref_primary_10_1007_s10585_018_9906_x
crossref_primary_10_1038_onc_2013_173
crossref_primary_10_3390_ijms252010982
crossref_primary_10_1038_s41580_018_0080_4
crossref_primary_10_1016_j_stem_2015_02_015
crossref_primary_10_1126_scisignal_2005189
crossref_primary_10_1158_0008_5472_CAN_12_2397
crossref_primary_10_18632_oncotarget_1875
crossref_primary_10_1038_s41568_021_00332_6
crossref_primary_10_1007_s13238_011_1041_2
crossref_primary_10_3390_cancers13051170
crossref_primary_10_1021_jf303690x
crossref_primary_10_1016_j_oraloncology_2010_12_001
crossref_primary_10_1038_s41388_019_0800_z
crossref_primary_10_3892_ol_2016_4404
crossref_primary_10_1371_journal_pone_0087207
crossref_primary_10_1016_j_bbamcr_2019_118537
crossref_primary_10_1038_onc_2013_55
crossref_primary_10_1038_s41388_017_0096_9
crossref_primary_10_18632_oncotarget_16849
crossref_primary_10_1371_journal_pone_0062493
crossref_primary_10_1016_j_cellsig_2011_11_020
crossref_primary_10_1016_j_cyto_2021_155709
crossref_primary_10_1016_j_biomaterials_2017_08_011
crossref_primary_10_1016_j_trecan_2020_03_011
crossref_primary_10_3390_ijms22052778
crossref_primary_10_1136_jclinpath_2015_202868
crossref_primary_10_1186_s41232_017_0041_x
crossref_primary_10_1172_JCI63608
crossref_primary_10_1186_s12935_020_01327_3
crossref_primary_10_1016_j_critrevonc_2013_10_001
crossref_primary_10_1111_vco_12235
crossref_primary_10_1007_s13277_014_2899_4
crossref_primary_10_3892_ol_2012_954
crossref_primary_10_1186_s12964_021_00750_x
crossref_primary_10_5858_arpa_2014_0498_RA
crossref_primary_10_1186_1476_4598_10_99
crossref_primary_10_1007_s10555_024_10171_0
crossref_primary_10_3892_or_2022_8320
crossref_primary_10_1002_mnfr_201700844
crossref_primary_10_1016_j_canlet_2016_09_027
crossref_primary_10_1016_j_prp_2015_12_011
crossref_primary_10_1007_s10585_011_9395_7
crossref_primary_10_3390_cells9102204
crossref_primary_10_1371_journal_pone_0190245
crossref_primary_10_1097_BS9_0000000000000079
crossref_primary_10_1093_jnci_djt022
crossref_primary_10_1155_2015_865816
crossref_primary_10_3892_ijo_2014_2292
crossref_primary_10_1016_j_lfs_2020_117438
crossref_primary_10_1007_s10555_023_10162_7
crossref_primary_10_1038_onc_2013_380
crossref_primary_10_3892_mmr_2015_3974
crossref_primary_10_1038_s41598_017_16625_6
crossref_primary_10_18632_oncotarget_3966
crossref_primary_10_1016_j_semcancer_2019_06_022
crossref_primary_10_3389_fonc_2023_1253191
crossref_primary_10_1146_annurev_cellbio_111315_125150
crossref_primary_10_1016_j_jid_2024_07_005
crossref_primary_10_3892_ijo_2017_3987
crossref_primary_10_1073_pnas_1618091114
crossref_primary_10_1016_j_neo_2015_01_004
crossref_primary_10_1007_s10555_013_9455_3
crossref_primary_10_1038_ncb1010_924
crossref_primary_10_1186_s12929_018_0440_6
crossref_primary_10_1186_s12935_024_03277_6
crossref_primary_10_1245_s10434_011_2074_8
crossref_primary_10_1016_j_canlet_2012_11_019
crossref_primary_10_1038_onc_2012_297
crossref_primary_10_1038_nrc3597
crossref_primary_10_3390_ijms21207613
crossref_primary_10_3389_fonc_2021_657546
crossref_primary_10_1016_j_jddst_2023_105275
crossref_primary_10_1002_jcb_23234
crossref_primary_10_6000_1927_7229_2015_04_04_8
crossref_primary_10_1073_pnas_1222684110
crossref_primary_10_3109_21681805_2014_909529
crossref_primary_10_1016_j_sdentj_2019_05_010
crossref_primary_10_4161_cam_21326
crossref_primary_10_1007_s10353_015_0339_3
crossref_primary_10_1016_j_molonc_2015_01_007
crossref_primary_10_1016_j_oraloncology_2012_10_009
crossref_primary_10_4161_sgtp_20791
crossref_primary_10_1186_s13046_021_02147_7
crossref_primary_10_1002_gcc_22802
crossref_primary_10_1039_D0MA00455C
crossref_primary_10_1080_19424396_2016_12220977
crossref_primary_10_1111_jcmm_13638
crossref_primary_10_1177_1074248420952233
crossref_primary_10_1038_embor_2012_47
crossref_primary_10_3892_ijo_2017_3846
crossref_primary_10_1038_onc_2011_232
crossref_primary_10_3390_biomedicines12061134
crossref_primary_10_1016_j_febslet_2013_07_049
crossref_primary_10_18632_oncotarget_2428
crossref_primary_10_1186_bcr3317
crossref_primary_10_1038_s41388_020_1269_5
crossref_primary_10_3389_fonc_2015_00013
crossref_primary_10_3389_fonc_2020_00816
crossref_primary_10_1038_ncomms5697
crossref_primary_10_1177_0022034518808254
crossref_primary_10_1007_s00109_012_0917_9
crossref_primary_10_1083_jcb_201012085
crossref_primary_10_4252_wjsc_v8_i1_13
crossref_primary_10_1002_stem_2406
crossref_primary_10_3390_cancers15235694
crossref_primary_10_1038_bjc_2013_759
crossref_primary_10_1038_labinvest_2014_123
crossref_primary_10_1159_000505188
crossref_primary_10_1139_bcb_2015_0053
crossref_primary_10_1002_jcp_22595
crossref_primary_10_1038_onc_2016_439
crossref_primary_10_1038_s41392_020_00419_w
crossref_primary_10_1007_s11255_020_02474_2
crossref_primary_10_1074_jbc_RA119_008926
crossref_primary_10_1038_s41467_018_06564_9
crossref_primary_10_1093_carcin_bgv005
crossref_primary_10_1016_j_taap_2014_10_022
crossref_primary_10_1038_s41419_019_1640_z
crossref_primary_10_1371_journal_pgen_1002650
crossref_primary_10_1136_jitc_2022_004832
crossref_primary_10_1158_0008_5472_CAN_14_0826
crossref_primary_10_1038_ncomms8821
crossref_primary_10_1111_jcmm_13465
crossref_primary_10_1158_2159_8290_CD_19_1299
crossref_primary_10_18632_oncotarget_6261
crossref_primary_10_1016_j_apsb_2020_11_018
crossref_primary_10_1038_cr_2011_144
crossref_primary_10_1146_annurev_cellbio_092910_154036
crossref_primary_10_1158_0008_5472_CAN_11_0073
crossref_primary_10_1016_j_biopha_2020_109920
crossref_primary_10_1186_1471_2407_14_587
crossref_primary_10_1038_nm_3336
crossref_primary_10_1007_s00441_014_1912_y
crossref_primary_10_1016_j_lfs_2020_118362
crossref_primary_10_1155_2018_2834109
crossref_primary_10_1111_j_1365_2605_2011_01169_x
crossref_primary_10_3389_fonc_2020_00220
crossref_primary_10_1002_stem_1401
crossref_primary_10_1007_s13105_024_01022_1
crossref_primary_10_1016_j_humpath_2013_05_001
crossref_primary_10_1371_journal_pone_0081839
crossref_primary_10_1007_s00018_016_2303_1
crossref_primary_10_3389_fonc_2020_01678
crossref_primary_10_1371_journal_pgen_1005915
crossref_primary_10_3892_ijmm_2015_2293
crossref_primary_10_1007_s00018_017_2496_y
crossref_primary_10_1158_0008_5472_CAN_18_2376
crossref_primary_10_7554_eLife_02313
crossref_primary_10_1038_onc_2011_263
crossref_primary_10_1016_j_jcrpr_2016_03_002
crossref_primary_10_1186_s12943_020_01288_1
crossref_primary_10_1007_s00018_011_0808_1
crossref_primary_10_1158_1078_0432_CCR_15_2665
crossref_primary_10_1186_s13046_016_0359_2
crossref_primary_10_1016_j_fct_2022_113564
crossref_primary_10_1002_mc_21983
crossref_primary_10_1038_s41467_018_06268_0
crossref_primary_10_1016_j_surg_2013_05_004
crossref_primary_10_1155_2021_2231680
crossref_primary_10_1016_j_ceb_2011_08_002
crossref_primary_10_1016_j_bbcan_2012_12_002
crossref_primary_10_3390_cancers11060862
crossref_primary_10_1038_ncomms4649
crossref_primary_10_3892_or_2016_5244
crossref_primary_10_1038_s41419_024_06567_z
crossref_primary_10_1016_j_bbagrm_2016_06_002
crossref_primary_10_1016_j_tranon_2016_10_004
crossref_primary_10_1016_j_surg_2013_05_012
crossref_primary_10_1186_s12943_023_01877_w
crossref_primary_10_1074_jbc_M110_168625
crossref_primary_10_1080_13543776_2021_1874345
crossref_primary_10_1158_0008_5472_CAN_11_3660
crossref_primary_10_1158_0008_5472_CAN_12_4085
crossref_primary_10_3389_fonc_2020_00792
crossref_primary_10_4161_cc_10_12_15688
crossref_primary_10_1016_j_jconrel_2019_01_011
crossref_primary_10_1097_MPA_0000000000000315
crossref_primary_10_1016_j_ajpath_2015_04_026
crossref_primary_10_1038_ncb2455
crossref_primary_10_3389_fcell_2023_1101480
crossref_primary_10_1016_j_canlet_2013_09_013
crossref_primary_10_1186_1471_2407_14_785
crossref_primary_10_3390_cancers14040916
crossref_primary_10_1093_pcmedi_pbz016
crossref_primary_10_1186_s12943_016_0577_4
crossref_primary_10_3389_fendo_2020_00058
crossref_primary_10_1016_j_biopha_2022_112616
crossref_primary_10_1016_j_celrep_2015_12_064
crossref_primary_10_3390_cancers13081772
crossref_primary_10_5402_2012_382010
crossref_primary_10_3390_biomedicines11113001
crossref_primary_10_1158_1541_7786_MCR_22_0139
crossref_primary_10_1016_j_pharmthera_2016_01_011
crossref_primary_10_1038_onc_2013_53
crossref_primary_10_1039_D1FO01611C
crossref_primary_10_1016_j_bbcan_2017_06_006
crossref_primary_10_1016_j_ajpath_2013_01_009
crossref_primary_10_1016_j_canlet_2012_07_010
crossref_primary_10_1101_gad_267757_115
crossref_primary_10_3390_life14111431
crossref_primary_10_4252_wjsc_v5_i3_61
crossref_primary_10_3389_fendo_2017_00284
crossref_primary_10_1186_1471_2407_14_651
crossref_primary_10_1007_s12035_016_9686_8
crossref_primary_10_3390_cancers14081894
crossref_primary_10_1038_srep00434
crossref_primary_10_1042_BSR20182161
crossref_primary_10_32604_or_2024_053764
crossref_primary_10_1002_cam4_2016
crossref_primary_10_1038_onc_2011_181
crossref_primary_10_1002_hep_27721
crossref_primary_10_1534_g3_120_401785
crossref_primary_10_1093_humupd_dmy035
crossref_primary_10_1039_c5pp00027k
crossref_primary_10_1091_mbc_e14_01_0044
crossref_primary_10_1080_21655979_2021_1948487
crossref_primary_10_3892_ol_2018_9230
crossref_primary_10_1016_j_bulcan_2017_10_011
crossref_primary_10_3390_ijms21134734
crossref_primary_10_1038_s41388_019_0904_5
crossref_primary_10_15252_embj_2021108647
crossref_primary_10_1016_j_toxlet_2014_11_001
crossref_primary_10_3892_or_2016_5255
crossref_primary_10_3390_cancers11050616
crossref_primary_10_1038_ncb2477
crossref_primary_10_1016_j_biopha_2016_03_010
crossref_primary_10_1002_advs_202301802
crossref_primary_10_1007_s12035_019_01836_x
crossref_primary_10_1016_j_ajpath_2011_07_011
crossref_primary_10_1038_pr_2011_62
crossref_primary_10_3390_cancers30100716
crossref_primary_10_1007_s11434_012_5225_9
crossref_primary_10_3390_jpm12040556
crossref_primary_10_7314_APJCP_2013_14_10_5579
crossref_primary_10_1007_s10555_015_9574_0
crossref_primary_10_3892_ijo_2024_5636
crossref_primary_10_1016_j_oraloncology_2013_06_010
crossref_primary_10_1074_jbc_RA117_001211
crossref_primary_10_1002_ijc_30067
crossref_primary_10_18632_oncotarget_3159
crossref_primary_10_3390_ijms19082411
crossref_primary_10_1186_s12943_019_0981_7
crossref_primary_10_1007_s10585_015_9717_2
crossref_primary_10_1038_s41419_021_04297_0
crossref_primary_10_1038_cddis_2014_549
crossref_primary_10_1111_odi_12608
crossref_primary_10_1111_febs_13895
crossref_primary_10_1158_0008_5472_CAN_14_3265
crossref_primary_10_3892_ijo_2019_4754
crossref_primary_10_1111_jcmm_13060
crossref_primary_10_1002_mc_22772
crossref_primary_10_1111_ajco_12843
crossref_primary_10_3390_ncrna7030045
crossref_primary_10_1016_j_oraloncology_2011_10_004
crossref_primary_10_3390_ijms242417539
crossref_primary_10_4143_crt_2012_44_3_151
crossref_primary_10_1089_ten_teb_2022_0052
crossref_primary_10_3892_mmr_2015_3192
crossref_primary_10_1002_stem_1803
crossref_primary_10_1038_s12276_023_00975_5
crossref_primary_10_1016_j_ccell_2015_12_006
crossref_primary_10_4103_ijpm_ijpm_467_23
crossref_primary_10_1371_journal_pone_0037765
crossref_primary_10_1186_s12935_017_0481_z
crossref_primary_10_1016_j_ydbio_2016_08_016
crossref_primary_10_1080_15384047_2015_1026472
crossref_primary_10_1016_j_stem_2017_02_003
crossref_primary_10_3390_cells9030623
crossref_primary_10_1016_j_lfs_2022_120754
crossref_primary_10_3892_or_2016_4804
crossref_primary_10_3389_fonc_2021_799223
crossref_primary_10_1146_annurev_pathol_012615_044438
crossref_primary_10_1038_onc_2016_286
crossref_primary_10_1177_0022034512467352
crossref_primary_10_1111_jgh_12652
crossref_primary_10_1177_1534735420972486
crossref_primary_10_1111_iju_13229
crossref_primary_10_4049_jimmunol_1402808
crossref_primary_10_1111_odi_13967
crossref_primary_10_1155_2016_9714315
crossref_primary_10_1186_s12929_020_00632_3
crossref_primary_10_4137_BIC_S33376
crossref_primary_10_1158_0008_5472_CAN_12_2505
crossref_primary_10_1007_s12035_024_04408_w
crossref_primary_10_1007_s00018_012_1122_2
crossref_primary_10_18632_oncotarget_5484
crossref_primary_10_1016_j_advms_2021_03_004
crossref_primary_10_1038_bcj_2015_67
crossref_primary_10_1016_j_heliyon_2023_e23501
crossref_primary_10_1158_0008_5472_CAN_14_3208
crossref_primary_10_1002_1878_0261_12082
crossref_primary_10_1111_jcmm_17453
crossref_primary_10_3390_cancers5041545
crossref_primary_10_1158_0008_5472_CAN_13_3319
crossref_primary_10_1371_journal_pone_0040943
crossref_primary_10_3390_ijms22147398
crossref_primary_10_1007_s00018_014_1654_8
crossref_primary_10_3892_or_2014_3298
crossref_primary_10_1007_s10555_016_9644_y
crossref_primary_10_1017_erm_2023_4
crossref_primary_10_1002_mco2_144
crossref_primary_10_1111_nan_12585
crossref_primary_10_1002_1878_0261_12096
crossref_primary_10_1007_s12307_011_0089_0
crossref_primary_10_1038_emboj_2013_37
crossref_primary_10_1038_nrc2940
crossref_primary_10_1016_j_trecan_2017_06_002
crossref_primary_10_1074_jbc_M111_258947
crossref_primary_10_1038_ncb2976
crossref_primary_10_3892_or_2017_5406
crossref_primary_10_1016_j_oraloncology_2020_104948
crossref_primary_10_1002_jcp_24229
crossref_primary_10_1002_mc_22335
crossref_primary_10_1002_mc_22221
crossref_primary_10_3389_froh_2023_1080255
crossref_primary_10_1007_s10585_014_9637_6
crossref_primary_10_1007_s11523_017_0501_x
crossref_primary_10_1038_onc_2013_515
crossref_primary_10_1016_j_gendis_2015_04_001
crossref_primary_10_1038_s41388_018_0457_z
crossref_primary_10_3892_or_2013_2897
crossref_primary_10_1007_s11010_011_1195_5
crossref_primary_10_1016_j_pbiomolbio_2023_06_003
crossref_primary_10_4161_cc_25331
crossref_primary_10_1021_acs_jafc_6b04101
crossref_primary_10_1159_000358598
crossref_primary_10_1186_1476_4598_13_207
crossref_primary_10_1016_j_semcancer_2012_04_001
crossref_primary_10_1242_dev_071209
crossref_primary_10_1016_j_radonc_2020_06_023
crossref_primary_10_1093_carcin_bgt364
crossref_primary_10_1158_0008_5472_CAN_15_0930
crossref_primary_10_1093_carcin_bgt369
crossref_primary_10_3390_cancers3010747
crossref_primary_10_3390_ijms25042173
crossref_primary_10_1002_cam4_3869
crossref_primary_10_1016_j_ceb_2013_01_008
crossref_primary_10_1016_j_ceb_2013_01_009
crossref_primary_10_1016_j_ebiom_2019_11_044
crossref_primary_10_1021_acs_molpharmaceut_6b00230
crossref_primary_10_1158_0008_5472_CAN_13_3231
crossref_primary_10_1073_pnas_1018866109
crossref_primary_10_1158_0008_5472_CAN_17_1545
crossref_primary_10_1016_j_abb_2021_108984
crossref_primary_10_1016_j_canlet_2012_05_014
crossref_primary_10_4236_jct_2015_66055
crossref_primary_10_1007_s10555_013_9483_z
crossref_primary_10_1007_s12033_023_00838_4
crossref_primary_10_1007_s12094_016_1555_4
crossref_primary_10_1016_j_cub_2012_04_024
crossref_primary_10_1007_s10555_012_9382_8
crossref_primary_10_1111_jog_12995
crossref_primary_10_3390_cancers3010415
crossref_primary_10_1016_j_gene_2022_147129
crossref_primary_10_1038_nrc3447
crossref_primary_10_1186_1471_2407_11_350
crossref_primary_10_1111_j_1600_0714_2011_01015_x
crossref_primary_10_3892_or_2011_1615
crossref_primary_10_1186_s13045_022_01347_8
crossref_primary_10_4252_wjsc_v6_i1_24
crossref_primary_10_1002_mnfr_201200150
crossref_primary_10_3390_ijms13044564
crossref_primary_10_1074_jbc_M112_365163
crossref_primary_10_1016_j_semcancer_2012_02_013
crossref_primary_10_1111_bjd_17995
crossref_primary_10_1371_journal_pone_0039520
crossref_primary_10_1111_febs_12299
crossref_primary_10_1016_j_bbrc_2015_09_021
crossref_primary_10_1016_j_jss_2012_07_066
crossref_primary_10_18632_oncotarget_3536
crossref_primary_10_3892_ijo_2015_3142
crossref_primary_10_1371_journal_pone_0018023
crossref_primary_10_1158_1541_7786_MCR_11_0371
crossref_primary_10_1161_CIRCRESAHA_115_306751
crossref_primary_10_18632_oncotarget_20144
crossref_primary_10_1097_MD_0000000000007346
crossref_primary_10_1016_j_ccr_2012_08_003
crossref_primary_10_1371_journal_pone_0028053
crossref_primary_10_1074_jbc_M112_387761
crossref_primary_10_1016_j_ydbio_2012_03_014
crossref_primary_10_1016_j_ajoms_2016_03_008
crossref_primary_10_1016_j_molonc_2012_10_009
crossref_primary_10_1038_onc_2015_195
crossref_primary_10_1038_onc_2015_84
crossref_primary_10_3727_096504017X15041934685237
crossref_primary_10_1111_iju_13404
crossref_primary_10_3390_jcm5030037
crossref_primary_10_1016_j_tig_2017_08_004
crossref_primary_10_1038_mt_2012_2
crossref_primary_10_1080_19336918_2021_1882782
crossref_primary_10_1038_srep29822
crossref_primary_10_3390_ijms19113672
crossref_primary_10_1016_j_cytogfr_2017_05_008
crossref_primary_10_3892_ijo_2012_1673
crossref_primary_10_4103_JCRP_JCRP_30_21
crossref_primary_10_3892_ol_2017_7155
crossref_primary_10_18632_oncotarget_14608
crossref_primary_10_3390_cancers13030418
crossref_primary_10_1158_1535_7163_MCT_12_0304
crossref_primary_10_1016_j_tcb_2014_06_005
crossref_primary_10_1016_j_biochi_2019_05_016
crossref_primary_10_1158_2326_6066_CIR_23_0622
crossref_primary_10_1016_j_semcdb_2016_09_004
crossref_primary_10_1186_s12967_016_0777_0
crossref_primary_10_1002_jcp_27589
crossref_primary_10_1186_bcr2789
crossref_primary_10_1016_j_bbcan_2022_188750
crossref_primary_10_1146_annurev_pathmechdis_051222_122423
crossref_primary_10_1038_onc_2014_172
crossref_primary_10_1038_s44321_024_00152_9
crossref_primary_10_1038_onc_2014_174
crossref_primary_10_1016_j_anndiagpath_2015_10_015
crossref_primary_10_1038_nrm3758
crossref_primary_10_1038_s41419_021_03491_4
crossref_primary_10_1007_s13277_013_1002_x
crossref_primary_10_1002_mc_23482
crossref_primary_10_1016_j_isci_2023_106946
crossref_primary_10_1093_nar_gkw334
crossref_primary_10_1016_j_pan_2019_09_005
crossref_primary_10_1111_febs_13112
crossref_primary_10_1016_j_bbcan_2012_01_003
crossref_primary_10_3342_kjorl_hns_2020_00612
crossref_primary_10_18632_oncotarget_13755
crossref_primary_10_1111_j_1440_1681_2011_05594_x
crossref_primary_10_1172_JCI94844
crossref_primary_10_1002_ijc_28727
crossref_primary_10_1002_ijc_26311
crossref_primary_10_1007_s13277_015_4450_7
crossref_primary_10_1007_s40496_014_0024_9
crossref_primary_10_1007_s11010_013_1745_0
crossref_primary_10_1002_ijc_26312
crossref_primary_10_15252_embr_202356902
crossref_primary_10_1016_j_ebiom_2019_07_071
crossref_primary_10_1186_1471_2407_12_114
crossref_primary_10_3892_or_2015_4032
crossref_primary_10_1186_s13046_019_1363_0
crossref_primary_10_1016_j_drup_2011_04_003
crossref_primary_10_3892_or_2017_5376
crossref_primary_10_4161_cbt_19851
crossref_primary_10_1186_s12918_017_0393_5
crossref_primary_10_1016_j_canlet_2021_08_008
crossref_primary_10_1038_s41419_019_1512_6
crossref_primary_10_1038_s41556_018_0268_z
crossref_primary_10_1097_PAT_0b013e328360b600
crossref_primary_10_1158_0008_5472_CAN_12_0299
crossref_primary_10_18632_oncotarget_3113
crossref_primary_10_1016_j_bbagen_2014_08_005
crossref_primary_10_3389_fphar_2021_830340
crossref_primary_10_1016_j_tem_2011_12_001
crossref_primary_10_3390_cancers12102792
crossref_primary_10_1016_j_ajpath_2013_06_021
crossref_primary_10_1111_jcmm_12851
crossref_primary_10_1186_s12943_019_0983_5
crossref_primary_10_1038_onc_2013_128
crossref_primary_10_1038_onc_2017_69
crossref_primary_10_18632_oncotarget_16925
crossref_primary_10_1002_jso_23067
crossref_primary_10_18632_oncotarget_11113
crossref_primary_10_3390_ijms20020275
crossref_primary_10_1016_j_ejca_2013_09_025
crossref_primary_10_18632_oncotarget_5406
crossref_primary_10_1126_sciadv_adj4678
crossref_primary_10_1186_s12935_023_03010_9
crossref_primary_10_1016_j_jss_2014_07_037
crossref_primary_10_1016_j_yexcr_2018_07_046
crossref_primary_10_1038_ncomms4070
crossref_primary_10_3390_biomedicines9060591
crossref_primary_10_1155_2016_5285892
crossref_primary_10_1016_j_semcancer_2011_09_014
crossref_primary_10_1016_j_semcancer_2014_05_005
crossref_primary_10_1042_BSR20100114
crossref_primary_10_1093_jnci_djs648
crossref_primary_10_1186_1471_2407_12_377
crossref_primary_10_5217_ir_2013_11_2_85
crossref_primary_10_1007_s13277_014_2163_y
crossref_primary_10_1177_09731296241299496
crossref_primary_10_1038_onc_2015_289
crossref_primary_10_1155_2016_6439864
crossref_primary_10_20538_1682_0363_2021_3_182_192
crossref_primary_10_3390_ijms241914481
crossref_primary_10_1016_j_molmed_2014_09_008
crossref_primary_10_3892_or_2017_5478
crossref_primary_10_1038_onc_2014_241
crossref_primary_10_1002_ijc_28761
crossref_primary_10_1002_stem_1274
crossref_primary_10_1016_j_biopha_2019_109346
crossref_primary_10_1016_j_canlet_2014_12_004
crossref_primary_10_1084_jem_20120812
crossref_primary_10_1016_j_tiv_2017_12_016
crossref_primary_10_1038_ncomms8207
crossref_primary_10_1016_j_diff_2016_05_008
crossref_primary_10_3390_biom5043396
crossref_primary_10_1038_onc_2015_291
crossref_primary_10_1155_2014_903259
crossref_primary_10_1002_stem_1035
crossref_primary_10_1038_ncb2910
crossref_primary_10_1038_onc_2014_374
crossref_primary_10_3390_ijms22179150
crossref_primary_10_1007_s10549_018_05089_5
Cites_doi 10.1128/MCB.00323-08
10.1038/ncb1998
10.1002/hed.20543
10.1101/gad.1299305
10.1038/16476
10.1073/pnas.0805706105
10.1038/nature04940
10.2353/ajpath.2010.090502
10.1128/MCB.24.6.2444-2454.2004
10.1016/S0092-8674(02)00975-3
10.1038/nature02060
10.1016/j.cell.2008.03.027
10.1016/j.immuni.2004.11.004
10.1158/1078-0432.CCR-05-1231
10.1038/sj.onc.1209929
10.1016/j.ijrobp.2008.10.040
10.1038/sj.bjc.6602510
10.1038/sj.bjc.6603529
10.1038/ng.165
10.1101/gad.276304
10.1038/ng1384
10.1002/hed.20908
10.1016/j.cell.2004.06.006
10.1101/gad.13.20.2678
10.1038/ncb1691
10.1016/j.cell.2007.04.019
10.1126/science.1062660
10.1016/j.cell.2004.08.005
10.1016/j.bbrc.2009.05.048
10.1200/JCO.2007.12.7662
10.1016/S0092-8674(02)00976-5
10.1073/pnas.0610117104
10.1038/ng1941
10.4161/cc.7.14.6324
10.1186/gb-2008-9-5-r83
10.1101/gad.269603
10.1128/MCB.01435-07
10.1073/pnas.95.14.7987
10.1371/journal.pone.0002888
10.1038/onc.2008.333
10.1128/MCB.24.1.306-319.2004
10.1016/j.stem.2007.08.014
10.1016/j.cell.2009.11.007
10.1593/neo.91326
10.1016/j.devcel.2005.09.010
10.1158/0008-5472.CAN-07-5882
10.1038/nature02385
10.1002/hed.20223
10.1093/jnci/92.7.569
10.1634/stemcells.2007-0821
10.1101/gad.415507
ContentType Journal Article
Copyright Springer Nature Limited 2010
COPYRIGHT 2010 Nature Publishing Group
Copyright Nature Publishing Group Oct 2010
Copyright_xml – notice: Springer Nature Limited 2010
– notice: COPYRIGHT 2010 Nature Publishing Group
– notice: Copyright Nature Publishing Group Oct 2010
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QL
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7X7
7XB
88A
88E
8AO
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
RC3
7X8
DOI 10.1038/ncb2099
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

ProQuest Central Student

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1476-4679
EndPage 992
ExternalDocumentID 2152134671
A239089312
20818389
10_1038_ncb2099
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID ---
.55
.GJ
0R~
123
29M
36B
39C
3V.
4.4
53G
5BI
5RE
70F
7X7
88A
88E
8AO
8FE
8FH
8FI
8FJ
8R4
8R5
AAEEF
AARCD
AAYZH
AAZLF
ABAWZ
ABCQX
ABDBF
ABEFU
ABJNI
ABLJU
ABNNU
ABUWG
ACBWK
ACGFS
ACIWK
ACNCT
ACPRK
ACRPL
ACUHS
ADBBV
ADNMO
ADQMX
AENEX
AEUYN
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AFWHJ
AGAYW
AGGDT
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
AIYXT
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
D0L
DB5
DU5
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IGS
IHR
INH
INR
ISR
ITC
J5H
L-9
L7B
LK8
M0L
M1P
M7P
N9A
NNMJJ
O9-
ODYON
P2P
PQQKQ
PROAC
PSQYO
Q2X
QF4
QM4
QN7
QO4
RNS
RNT
RNTTT
SHXYY
SIXXV
SKT
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TSG
TUS
UKHRP
X7M
Y6R
ZGI
~02
~8M
AAYXX
ABFSG
ACSTC
AFANA
AGQPQ
ALPWD
ATHPR
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7QL
7QP
7QR
7T5
7TK
7TM
7TO
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
7X8
ID FETCH-LOGICAL-c507t-271a7fcf0e4de93dc58b1574bb05c33b8f7d9aa7cd6a3996258ae817452f115c3
IEDL.DBID 7X7
ISSN 1465-7392
1476-4679
IngestDate Fri Jul 11 05:17:48 EDT 2025
Sat Aug 23 14:23:58 EDT 2025
Tue Jun 17 21:32:49 EDT 2025
Tue Jun 10 20:42:30 EDT 2025
Fri Jun 27 04:45:57 EDT 2025
Wed Feb 19 02:34:19 EST 2025
Tue Jul 01 00:31:06 EDT 2025
Thu Apr 24 23:06:07 EDT 2025
Fri Feb 21 02:40:11 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c507t-271a7fcf0e4de93dc58b1574bb05c33b8f7d9aa7cd6a3996258ae817452f115c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 20818389
PQID 756095734
PQPubID 45779
PageCount 11
ParticipantIDs proquest_miscellaneous_757175452
proquest_journals_756095734
gale_infotracmisc_A239089312
gale_infotracacademiconefile_A239089312
gale_incontextgauss_ISR_A239089312
pubmed_primary_20818389
crossref_citationtrail_10_1038_ncb2099
crossref_primary_10_1038_ncb2099
springer_journals_10_1038_ncb2099
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-10-01
PublicationDateYYYYMMDD 2010-10-01
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature cell biology
PublicationTitleAbbrev Nat Cell Biol
PublicationTitleAlternate Nat Cell Biol
PublicationYear 2010
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Yang (CR24) 2008; 10
Androutsellis-Theotokis (CR40) 2006; 442
Yang, Wu (CR35) 2008; 7
Li (CR36) 2010; 176
Herranz (CR33) 2008; 28
Hoogsteen, Marres, Bussink, van der Kogel, Kaanders (CR21) 2007; 29
Sangiorgi, Capecchi (CR8) 2008; 40
Gustafsson (CR38) 2005; 9
Hou (CR32) 2008; 28
Ginestier (CR43) 2007; 1
Molofsky (CR6) 2003; 425
Huang (CR44) 2008; 26
Vermeulen (CR28) 2008; 105
Vormittag (CR37) 2009; 73
Keith, Simon (CR25) 2007; 129
Kumar (CR51) 2008; 26
Peinado, Ballestar, Esteller, Cano (CR31) 2004; 24
Tamura (CR30) 2000; 92
Chiba (CR18) 2008; 68
Furlong, Andersen, Null, White, Scott (CR22) 2001; 293
Yang (CR23) 2004; 117
Chen (CR26) 2009; 385
Widschwendter (CR5) 2007; 39
Huang, Gu, Schau, Bunn (CR27) 1998; 95
Yang (CR42) 2006; 12
Thiery, Acloque, Huang, Nieto (CR1) 2009; 139
Iwama (CR7) 2004; 21
Huang (CR41) 2009; 11
Prince (CR17) 2007; 104
Birnie (CR46) 2008; 9
Czermin (CR11) 2002; 111
Wellner (CR34) 2009; 11
Morel (CR3) 2008; 3
Min, Zhang, Xu (CR13) 2003; 17
Yang (CR47) 2007; 26
Bracken (CR14) 2007; 21
Janssen, Haustermans, Balm, Begg (CR20) 2005; 27
Müller (CR12) 2002; 111
Jacobs, Kieboom, Marino, Depinho, van Lohuizen (CR9) 1999; 397
Kang (CR49) 2007; 96
Mani (CR2) 2008; 133
Foschini (CR50) 2008; 30
Valk-Lingbeek, Bruggeman, van Lohuizen (CR4) 2004; 118
Cao (CR29) 2008; 27
Seiwert, Cohen (CR19) 2005; 92
Timmerman (CR39) 2004; 18
Ainbinder, Amir-Zilberstein, Yamaguchi, Handa, Dikstein (CR48) 2004; 24
Bruggeman (CR10) 2005; 19
Wang (CR45) 2004; 36
Jacobs (CR15) 1999; 13
Leung (CR16) 2004; 428
SA Mani (BFncb2099_CR2) 2008; 133
IJ Hoogsteen (BFncb2099_CR21) 2007; 29
T Chiba (BFncb2099_CR18) 2008; 68
EE Furlong (BFncb2099_CR22) 2001; 293
B Kumar (BFncb2099_CR51) 2008; 26
HL Janssen (BFncb2099_CR20) 2005; 27
E Ainbinder (BFncb2099_CR48) 2004; 24
SW Bruggeman (BFncb2099_CR10) 2005; 19
MH Yang (BFncb2099_CR42) 2006; 12
J Müller (BFncb2099_CR12) 2002; 111
CH Huang (BFncb2099_CR41) 2009; 11
TY Seiwert (BFncb2099_CR19) 2005; 92
HW Wang (BFncb2099_CR45) 2004; 36
Q Cao (BFncb2099_CR29) 2008; 27
TS Huang (BFncb2099_CR44) 2008; 26
J Yang (BFncb2099_CR23) 2004; 117
E Sangiorgi (BFncb2099_CR8) 2008; 40
MH Yang (BFncb2099_CR35) 2008; 7
JJ Jacobs (BFncb2099_CR15) 1999; 13
ME Prince (BFncb2099_CR17) 2007; 104
A Androutsellis-Theotokis (BFncb2099_CR40) 2006; 442
J Li (BFncb2099_CR36) 2010; 176
R Birnie (BFncb2099_CR46) 2008; 9
N Herranz (BFncb2099_CR33) 2008; 28
MP Foschini (BFncb2099_CR50) 2008; 30
B Czermin (BFncb2099_CR11) 2002; 111
AV Molofsky (BFncb2099_CR6) 2003; 425
Z Hou (BFncb2099_CR32) 2008; 28
M Widschwendter (BFncb2099_CR5) 2007; 39
L Vermeulen (BFncb2099_CR28) 2008; 105
J Min (BFncb2099_CR13) 2003; 17
LE Huang (BFncb2099_CR27) 1998; 95
AP Bracken (BFncb2099_CR14) 2007; 21
A Iwama (BFncb2099_CR7) 2004; 21
MH Yang (BFncb2099_CR24) 2008; 10
MK Kang (BFncb2099_CR49) 2007; 96
AP Morel (BFncb2099_CR3) 2008; 3
ME Valk-Lingbeek (BFncb2099_CR4) 2004; 118
JJ Jacobs (BFncb2099_CR9) 1999; 397
C Ginestier (BFncb2099_CR43) 2007; 1
YC Chen (BFncb2099_CR26) 2009; 385
MV Gustafsson (BFncb2099_CR38) 2005; 9
JP Thiery (BFncb2099_CR1) 2009; 139
H Peinado (BFncb2099_CR31) 2004; 24
G Tamura (BFncb2099_CR30) 2000; 92
U Wellner (BFncb2099_CR34) 2009; 11
MH Yang (BFncb2099_CR47) 2007; 26
C Leung (BFncb2099_CR16) 2004; 428
LA Timmerman (BFncb2099_CR39) 2004; 18
B Keith (BFncb2099_CR25) 2007; 129
L Vormittag (BFncb2099_CR37) 2009; 73
20885418 - Nat Cell Biol. 2010 Oct;12(10):924-5
30833696 - Nat Cell Biol. 2019 Mar 4
21080568 - Nat Rev Cancer. 2010 Oct;10(10):666
References_xml – volume: 28
  start-page: 4772
  year: 2008
  end-page: 4781
  ident: CR33
  article-title: Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.00323-08
– volume: 11
  start-page: 1487
  year: 2009
  end-page: 95
  ident: CR34
  article-title: The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1998
– volume: 29
  start-page: 591
  year: 2007
  end-page: 604
  ident: CR21
  article-title: Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review
  publication-title: Head Neck
  doi: 10.1002/hed.20543
– volume: 19
  start-page: 1438
  year: 2005
  end-page: 1443
  ident: CR10
  article-title: Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice
  publication-title: Genes & Dev.
  doi: 10.1101/gad.1299305
– volume: 397
  start-page: 164
  year: 1999
  end-page: 168
  ident: CR9
  article-title: The oncogene and polycomb-group gene regulates cell proliferation and senescence through the locus
  publication-title: Nature
  doi: 10.1038/16476
– volume: 105
  start-page: 13427
  year: 2008
  end-page: 13432
  ident: CR28
  article-title: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.0805706105
– volume: 442
  start-page: 823
  year: 2006
  end-page: 826
  ident: CR40
  article-title: Notch signalling regulates stem cell numbers and
  publication-title: Nature
  doi: 10.1038/nature04940
– volume: 176
  start-page: 699
  year: 2010
  end-page: 709
  ident: CR36
  article-title: Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-κB pathway
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.090502
– volume: 24
  start-page: 2444
  year: 2004
  end-page: 2454
  ident: CR48
  article-title: Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-κB
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.24.6.2444-2454.2004
– volume: 111
  start-page: 185
  year: 2002
  end-page: 196
  ident: CR11
  article-title: Enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00975-3
– volume: 425
  start-page: 962
  year: 2003
  end-page: 967
  ident: CR6
  article-title: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
  publication-title: Nature
  doi: 10.1038/nature02060
– volume: 133
  start-page: 704
  year: 2008
  end-page: 715
  ident: CR2
  article-title: The epithelial–mesenchymal transition generates cells with properties of stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2008.03.027
– volume: 21
  start-page: 843
  year: 2004
  end-page: 851
  ident: CR7
  article-title: Enhanced self-renewal of haematopoietic stem cells mediated by the polycomb gene product Bmi-1
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.11.004
– volume: 12
  start-page: 507
  year: 2006
  end-page: 515
  ident: CR42
  article-title: Increased expression is a marker of aggressive head and neck cancer and overexpression of contributes to transformation
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-1231
– volume: 26
  start-page: 1459
  year: 2007
  end-page: 1467
  ident: CR47
  article-title: Overexpression of NBS1 induces epithelial–mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209929
– volume: 73
  start-page: 913
  year: 2009
  end-page: 918
  ident: CR37
  article-title: Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2008.10.040
– volume: 92
  start-page: 1341
  year: 2005
  end-page: 1348
  ident: CR19
  article-title: State-of-the-art management of locally advanced head and neck cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6602510
– volume: 96
  start-page: 126
  year: 2007
  end-page: 133
  ident: CR49
  article-title: Elevated expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603529
– volume: 40
  start-page: 915
  year: 2008
  end-page: 920
  ident: CR8
  article-title: Bmi1 is expressed in intestinal stem cells
  publication-title: Nat. Genet.
  doi: 10.1038/ng.165
– volume: 18
  start-page: 99
  year: 2004
  end-page: 115
  ident: CR39
  article-title: Notch promotes epithelial–mesenchymal transition during cardiac development and oncogenic transformation
  publication-title: Genes Dev.
  doi: 10.1101/gad.276304
– volume: 36
  start-page: 687
  year: 2004
  end-page: 693
  ident: CR45
  article-title: Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma
  publication-title: Nat. Genet.
  doi: 10.1038/ng1384
– volume: 30
  start-page: 1475
  year: 2008
  end-page: 1482
  ident: CR50
  article-title: E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior
  publication-title: Head Neck
  doi: 10.1002/hed.20908
– volume: 117
  start-page: 927
  year: 2004
  end-page: 939
  ident: CR23
  article-title: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
  publication-title: Cell
  doi: 10.1016/j.cell.2004.06.006
– volume: 13
  start-page: 2678
  year: 1999
  end-page: 2690
  ident: CR15
  article-title: Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
  publication-title: Genes Dev.
  doi: 10.1101/gad.13.20.2678
– volume: 10
  start-page: 295
  year: 2008
  end-page: 305
  ident: CR24
  article-title: Direct regulation of TWIST by HIF-1α promotes metastasis
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1691
– volume: 129
  start-page: 465
  year: 2007
  end-page: 472
  ident: CR25
  article-title: Hypoxia-inducible factors, stem cells and cancer
  publication-title: Cell
  doi: 10.1016/j.cell.2007.04.019
– volume: 293
  start-page: 1629
  year: 2001
  end-page: 1633
  ident: CR22
  article-title: Patterns of gene expression during mesoderm development
  publication-title: Science
  doi: 10.1126/science.1062660
– volume: 118
  start-page: 409
  year: 2004
  end-page: 418
  ident: CR4
  article-title: Stem cells and cancer: the polycomb connection
  publication-title: Cell
  doi: 10.1016/j.cell.2004.08.005
– volume: 385
  start-page: 307
  year: 2009
  end-page: 313
  ident: CR26
  article-title: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2009.05.048
– volume: 26
  start-page: 3128
  year: 2008
  end-page: 3137
  ident: CR51
  article-title: EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.12.7662
– volume: 111
  start-page: 197
  year: 2002
  end-page: 208
  ident: CR12
  article-title: Histone methyltransferase activity of a polycomb group repressor complex
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00976-5
– volume: 104
  start-page: 973
  year: 2007
  end-page: 978
  ident: CR17
  article-title: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.0610117104
– volume: 39
  start-page: 157
  year: 2007
  end-page: 158
  ident: CR5
  article-title: Epigenetic stem cell signature in cancer
  publication-title: Nat. Genet.
  doi: 10.1038/ng1941
– volume: 7
  start-page: 2090
  year: 2008
  end-page: 2096
  ident: CR35
  article-title: TWIST activated by hypoxia inducible factor-1 (HIF-1): implication in metastasis and development
  publication-title: Cell Cycle
  doi: 10.4161/cc.7.14.6324
– volume: 9
  start-page: R83
  year: 2008
  ident: CR46
  article-title: Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions
  publication-title: Genome Biol.
  doi: 10.1186/gb-2008-9-5-r83
– volume: 17
  start-page: 1823
  year: 2003
  end-page: 1828
  ident: CR13
  article-title: Structural basis for specific binding of polycomb chromodomain to histone H3 methylated at Lys 27
  publication-title: Genes & Dev.
  doi: 10.1101/gad.269603
– volume: 28
  start-page: 3198
  year: 2008
  end-page: 3207
  ident: CR32
  article-title: The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.01435-07
– volume: 95
  start-page: 7987
  year: 1998
  end-page: 7992
  ident: CR27
  article-title: Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin–proteasome pathway
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.95.14.7987
– volume: 3
  start-page: e2888
  year: 2008
  ident: CR3
  article-title: Generation of breast cancer stem cells through epithelial–mesenchymal transition
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002888
– volume: 27
  start-page: 7274
  year: 2008
  end-page: 7284
  ident: CR29
  article-title: Repression of E-cadherin by the polycomb group protein EZH2 in cancer
  publication-title: Oncogene
  doi: 10.1038/onc.2008.333
– volume: 24
  start-page: 306
  year: 2004
  end-page: 319
  ident: CR31
  article-title: Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.24.1.306-319.2004
– volume: 1
  start-page: 555
  year: 2007
  end-page: 567
  ident: CR43
  article-title: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.08.014
– volume: 139
  start-page: 871
  year: 2009
  end-page: 890
  ident: CR1
  article-title: Epithelial–mesenchymal transitions in development and disease
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 11
  start-page: 1371
  year: 2009
  end-page: 1382
  ident: CR41
  article-title: Regulation of membrane-type 4 matrix metalloproteinase (MT4-MMP) by SLUG contributes to hypoxia-mediated metastasis
  publication-title: Neoplasia
  doi: 10.1593/neo.91326
– volume: 9
  start-page: 617
  year: 2005
  end-page: 628
  ident: CR38
  article-title: Hypoxia requires notch signaling to maintain the undifferentiated cell state
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2005.09.010
– volume: 68
  start-page: 7742
  year: 2008
  end-page: 7749
  ident: CR18
  article-title: The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5882
– volume: 428
  start-page: 337
  year: 2004
  end-page: 341
  ident: CR16
  article-title: Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas
  publication-title: Nature
  doi: 10.1038/nature02385
– volume: 27
  start-page: 622
  year: 2005
  end-page: 638
  ident: CR20
  article-title: Hypoxia in head and neck cancer: how much, how important?
  publication-title: Head Neck
  doi: 10.1002/hed.20223
– volume: 92
  start-page: 569
  year: 2000
  end-page: 573
  ident: CR30
  article-title: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/92.7.569
– volume: 26
  start-page: 1186
  year: 2008
  end-page: 1201
  ident: CR44
  article-title: Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2007-0821
– volume: 21
  start-page: 525
  year: 2007
  end-page: 530
  ident: CR14
  article-title: The polycomb group proteins bind throughout the locus and are disassociated in senescent cells
  publication-title: Genes & Dev.
  doi: 10.1101/gad.415507
– volume: 26
  start-page: 1186
  year: 2008
  ident: BFncb2099_CR44
  publication-title: Stem Cells
  doi: 10.1634/stemcells.2007-0821
– volume: 18
  start-page: 99
  year: 2004
  ident: BFncb2099_CR39
  publication-title: Genes Dev.
  doi: 10.1101/gad.276304
– volume: 13
  start-page: 2678
  year: 1999
  ident: BFncb2099_CR15
  publication-title: Genes Dev.
  doi: 10.1101/gad.13.20.2678
– volume: 26
  start-page: 3128
  year: 2008
  ident: BFncb2099_CR51
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.12.7662
– volume: 9
  start-page: 617
  year: 2005
  ident: BFncb2099_CR38
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2005.09.010
– volume: 385
  start-page: 307
  year: 2009
  ident: BFncb2099_CR26
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2009.05.048
– volume: 27
  start-page: 7274
  year: 2008
  ident: BFncb2099_CR29
  publication-title: Oncogene
  doi: 10.1038/onc.2008.333
– volume: 3
  start-page: e2888
  year: 2008
  ident: BFncb2099_CR3
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0002888
– volume: 96
  start-page: 126
  year: 2007
  ident: BFncb2099_CR49
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6603529
– volume: 104
  start-page: 973
  year: 2007
  ident: BFncb2099_CR17
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.0610117104
– volume: 425
  start-page: 962
  year: 2003
  ident: BFncb2099_CR6
  publication-title: Nature
  doi: 10.1038/nature02060
– volume: 9
  start-page: R83
  year: 2008
  ident: BFncb2099_CR46
  publication-title: Genome Biol.
  doi: 10.1186/gb-2008-9-5-r83
– volume: 11
  start-page: 1371
  year: 2009
  ident: BFncb2099_CR41
  publication-title: Neoplasia
  doi: 10.1593/neo.91326
– volume: 12
  start-page: 507
  year: 2006
  ident: BFncb2099_CR42
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-05-1231
– volume: 40
  start-page: 915
  year: 2008
  ident: BFncb2099_CR8
  publication-title: Nat. Genet.
  doi: 10.1038/ng.165
– volume: 73
  start-page: 913
  year: 2009
  ident: BFncb2099_CR37
  publication-title: Int. J. Radiat. Oncol. Biol. Phys.
  doi: 10.1016/j.ijrobp.2008.10.040
– volume: 1
  start-page: 555
  year: 2007
  ident: BFncb2099_CR43
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2007.08.014
– volume: 95
  start-page: 7987
  year: 1998
  ident: BFncb2099_CR27
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.95.14.7987
– volume: 68
  start-page: 7742
  year: 2008
  ident: BFncb2099_CR18
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-5882
– volume: 19
  start-page: 1438
  year: 2005
  ident: BFncb2099_CR10
  publication-title: Genes & Dev.
  doi: 10.1101/gad.1299305
– volume: 21
  start-page: 525
  year: 2007
  ident: BFncb2099_CR14
  publication-title: Genes & Dev.
  doi: 10.1101/gad.415507
– volume: 17
  start-page: 1823
  year: 2003
  ident: BFncb2099_CR13
  publication-title: Genes & Dev.
  doi: 10.1101/gad.269603
– volume: 11
  start-page: 1487
  year: 2009
  ident: BFncb2099_CR34
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1998
– volume: 428
  start-page: 337
  year: 2004
  ident: BFncb2099_CR16
  publication-title: Nature
  doi: 10.1038/nature02385
– volume: 129
  start-page: 465
  year: 2007
  ident: BFncb2099_CR25
  publication-title: Cell
  doi: 10.1016/j.cell.2007.04.019
– volume: 24
  start-page: 306
  year: 2004
  ident: BFncb2099_CR31
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.24.1.306-319.2004
– volume: 36
  start-page: 687
  year: 2004
  ident: BFncb2099_CR45
  publication-title: Nat. Genet.
  doi: 10.1038/ng1384
– volume: 21
  start-page: 843
  year: 2004
  ident: BFncb2099_CR7
  publication-title: Immunity
  doi: 10.1016/j.immuni.2004.11.004
– volume: 442
  start-page: 823
  year: 2006
  ident: BFncb2099_CR40
  publication-title: Nature
  doi: 10.1038/nature04940
– volume: 293
  start-page: 1629
  year: 2001
  ident: BFncb2099_CR22
  publication-title: Science
  doi: 10.1126/science.1062660
– volume: 24
  start-page: 2444
  year: 2004
  ident: BFncb2099_CR48
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.24.6.2444-2454.2004
– volume: 111
  start-page: 197
  year: 2002
  ident: BFncb2099_CR12
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00976-5
– volume: 10
  start-page: 295
  year: 2008
  ident: BFncb2099_CR24
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb1691
– volume: 133
  start-page: 704
  year: 2008
  ident: BFncb2099_CR2
  publication-title: Cell
  doi: 10.1016/j.cell.2008.03.027
– volume: 92
  start-page: 1341
  year: 2005
  ident: BFncb2099_CR19
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6602510
– volume: 27
  start-page: 622
  year: 2005
  ident: BFncb2099_CR20
  publication-title: Head Neck
  doi: 10.1002/hed.20223
– volume: 30
  start-page: 1475
  year: 2008
  ident: BFncb2099_CR50
  publication-title: Head Neck
  doi: 10.1002/hed.20908
– volume: 118
  start-page: 409
  year: 2004
  ident: BFncb2099_CR4
  publication-title: Cell
  doi: 10.1016/j.cell.2004.08.005
– volume: 176
  start-page: 699
  year: 2010
  ident: BFncb2099_CR36
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.090502
– volume: 105
  start-page: 13427
  year: 2008
  ident: BFncb2099_CR28
  publication-title: Proc. Natl Acad. Sci. USA.
  doi: 10.1073/pnas.0805706105
– volume: 111
  start-page: 185
  year: 2002
  ident: BFncb2099_CR11
  publication-title: Cell
  doi: 10.1016/S0092-8674(02)00975-3
– volume: 397
  start-page: 164
  year: 1999
  ident: BFncb2099_CR9
  publication-title: Nature
  doi: 10.1038/16476
– volume: 28
  start-page: 3198
  year: 2008
  ident: BFncb2099_CR32
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.01435-07
– volume: 92
  start-page: 569
  year: 2000
  ident: BFncb2099_CR30
  publication-title: J. Natl Cancer Inst.
  doi: 10.1093/jnci/92.7.569
– volume: 28
  start-page: 4772
  year: 2008
  ident: BFncb2099_CR33
  publication-title: Mol. Cell Biol.
  doi: 10.1128/MCB.00323-08
– volume: 7
  start-page: 2090
  year: 2008
  ident: BFncb2099_CR35
  publication-title: Cell Cycle
  doi: 10.4161/cc.7.14.6324
– volume: 26
  start-page: 1459
  year: 2007
  ident: BFncb2099_CR47
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209929
– volume: 139
  start-page: 871
  year: 2009
  ident: BFncb2099_CR1
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 29
  start-page: 591
  year: 2007
  ident: BFncb2099_CR21
  publication-title: Head Neck
  doi: 10.1002/hed.20543
– volume: 117
  start-page: 927
  year: 2004
  ident: BFncb2099_CR23
  publication-title: Cell
  doi: 10.1016/j.cell.2004.06.006
– volume: 39
  start-page: 157
  year: 2007
  ident: BFncb2099_CR5
  publication-title: Nat. Genet.
  doi: 10.1038/ng1941
– reference: 21080568 - Nat Rev Cancer. 2010 Oct;10(10):666
– reference: 20885418 - Nat Cell Biol. 2010 Oct;12(10):924-5
– reference: 30833696 - Nat Cell Biol. 2019 Mar 4;:
SSID ssj0014407
Score 2.5395536
Snippet The transcription factor Twist1 interacts with the Bmi1 polycomb group protein. This complex is proposed to regulate the epithelial–mesenchymal transition and...
The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 982
SubjectTerms 631/208/200
631/80/84/2176
692/699/67/1536
Cadherins - genetics
Cadherins - metabolism
Cancer
Cancer Research
Care and treatment
Cell Biology
Cell Line
Cell Transformation, Neoplastic - genetics
Chromatin
Chromatin Assembly and Disassembly
Developmental Biology
Down-Regulation
Epithelial cells
Epithelial Cells - metabolism
Epithelial Cells - pathology
Exons - genetics
Female
Genes, p16
Head and Neck Neoplasms - genetics
Head and Neck Neoplasms - metabolism
Head and Neck Neoplasms - pathology
Humans
Hypoxia
Life Sciences
Male
Mesoderm - metabolism
Mesoderm - pathology
Metastasis
Middle Aged
Neoplasm Metastasis - genetics
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Physiological aspects
Polycomb Repressive Complex 1
Prognosis
Promoter Regions, Genetic - genetics
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - metabolism
Repressor Proteins - genetics
Repressor Proteins - metabolism
Stem Cells
Transcription, Genetic
Tumors
Twist-Related Protein 1 - genetics
Twist-Related Protein 1 - metabolism
Title Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
URI https://link.springer.com/article/10.1038/ncb2099
https://www.ncbi.nlm.nih.gov/pubmed/20818389
https://www.proquest.com/docview/756095734
https://www.proquest.com/docview/757175452
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED8x0KS9TBvsI4OhDE3bk0UTx3XyNAEqAqQhxEDqW2Q7NqvUpt3SauK_353jBloknn2JHd-dfZe7-x3A177up064jBF6ODooqFIqc5ol0mSFc6rKfQT_52X_7Da7GIphyM1pQlrl8kz0B3U1NfSP_FAKgkaTPPsx-8OoaRQFV0MHjRewRchllNElh52_RWFL2RYXCSbRDmhrZgkR_LA2mmpGVy6j9SP50Z20FiT1d8_pG3gdjMb4qOXyW9iw9Ta8bNtI3u_A4HgySuJRExMOeI0qO45HdXzzDzmYMPS5kXtVbGdUfTHGQTahiiPz-36ChHO6q3za1ju4PR3cnJyx0B6BGTTi5iyViZLOuJ7NKlvwyohcJ0JmWveE4VznTlaFUtJUfYVmCDo6ubI5eiAidWgHGv4eNutpbT9CLEzBleGZR1dzVui8MInSouqpIskLG8G35T6VJmCHUwuLcelj2Dwvw4ZGEHeEsxYu4ynJAW10SeATNWW33KlF05Tnv67Lo5RTGJInaQTfA5Gb4kRGhWIBXC7hVa1Q7q1QonaYleHdJT_LoJ1N2ckSLrcbpQcp4ay20wWRoJ9L_dcj-NBKQfc9KaEAop0XwZelWDy8eu1jPz07_S688skIPjdwDzbnfxf2M9o4c73vJXkfto4Hl1fX_wG6Lvql
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NToi9THwTNiAgPp6iNbHdJA_TtEGnlm0VGp20t8x27FGpTTvSauofxf_IXb6gReJtz744tnO-j9zd7wDed1QnsMJyj9DD0UHBKyW5VZ4fah5bK9OoiOCfDTq9C_71UlxuwK-6FobSKmuZWAjqdKrpH_leKAgaLWT8YHbjUdMoCq7WHTRKrjgxy1v02PL9_hf8vB-C4Lg7_NzzqqYCnkbTZ-4FoS9Dq23b8NTELNUiUr4IuVJtoRlTkQ3TWMpQpx2Jyhvdg0iaCO12EVi0njTDee_BJmfoybRg86g7-HbehC04L-qzUfoIL0TLo6zSJQzyvUwrqlJdUX_rSuAvLbgWli203fFD2K7MVPew5KtHsGGyx3C_bFy5fALdo8nId0e5S8jjGQqJsTvK3OEt8ozvoZeP_JK6Zkb1HmMc9CZU46R_LCdIOCftWCSKPYWLOzm7Z9DKppl5Aa7QMZOa8QLPzRqholj7Uom0LWM_io0DH-tzSnSFVk5NM8ZJETVnUVIdqANuQzgrATr-JXlHB50Q3EVG-TTXcpHnSf_7eXIYMAp8Mj9w4FNFZKf4Ii2r8gRcLiFkrVDurlDifdQrwzv190wqeZAnDfficptRepBS3DIzXRAJetbU8d2B5yUXNPsJCHcQLUsH3tZs8Wfqtc2-_O_r38CD3vDsNDntD052YKtIhSgyE3ehNf-5MK_Qwpqr1xVfu3B111fpN6S6N5E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIhCXijduCxjE42Ql9nqz9qGqCm3UUKgQtFJu2931Lo2UOClOVOWn8e-Y8QsSJG4978SP9Tc7M5mZbwDe9HQvctzFAbGHY4CCKqVip4NQmDh1TmVJmcH_cto7Po8_DflwA341vTBUVtmcieVBnU0N_UfeEZyo0QSLO66uivh62N-fXQU0QIoSrc00jQohJ3Z5jdFbsTc4xE_9Nor6R2cfj4N6wEBg0A2aB5EIlXDGdW2c2ZRlhic65CLWussNYzpxIkuVEibrKTTkGCokyibow_PIoSdlGF73FtwWjIekYmLYxnqUMhVVYxMPBPogVb8usZF3cqOpX3XFEK6bg7_s4VqCtrR7_fuwVTus_kGFsAewYfOHcKcaYbl8BEcfJqPQHxU-cZDneFyM_VHun10jesIA431ETubbGXV-jHExmFC3k7lcTlBwTnayLBl7DOc3snNPYDOf5vYZ-NykTBkWl8xuznKdpCZUmmddlYZJaj141-yTNDVvOY3PGMsyf84SWW-oB34rOKuoOv4VeU0bLYn4IicM_VCLopCD79_kQcQoBcrCyIP3tZCb4o2MqhsV8HGJK2tFcndFEjXTrCzvNN9T1idDIVsc4-O2q_RDKnbL7XRBIhhj0-x3D55WKGjfJyIGQvQxPXjVwOLPpddedvu_t38Jd1GB5OfB6ckO3CtrIsoSxV3YnP9c2Ofoas31ixLUPlzctBb9BsjlOmE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bmi1+is+essential+in+Twist1-induced+epithelial-mesenchymal+transition&rft.jtitle=Nature+cell+biology&rft.au=Yang%2C+Muh-Hwa&rft.au=Hsu%2C+Dennis+Shin-Shian&rft.au=Wang%2C+Hsei-Wei&rft.au=Wang%2C+Hsiao-Jung&rft.date=2010-10-01&rft.issn=1476-4679&rft.eissn=1476-4679&rft.volume=12&rft.issue=10&rft.spage=982&rft_id=info:doi/10.1038%2Fncb2099&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-7392&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-7392&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-7392&client=summon